High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective.
High-dose-rate (HDR) brachytherapy as monotherapy is a comparatively new brachytherapy procedure for prostate cancer. Although clinical results are not yet mature enough, it is a highly promising approach in terms of potential benefits for both radiation physics and radiobiology. In this article, we describe our technique for monotherapeutic HDR prostate brachytherapy, as well as the rationale and theoretical background, with educational intent.
Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Yasuo
Y
Yoshioka
Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Osamu
O
Suzuki
Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Yuki
Y
Otani
Department of Radiology, Osaka Medical College, Osaka, Japan.
Ken
K
Yoshida
Department of Radiation Oncology, Nippon Medical School Tama Nagayama Hospital, Tokyo, Japan.
Takayuki
T
Nose
Department of Radiation Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kazuhiko
K
Ogawa
high-dose-rate (HDR) brachytherapy; hypofractionation; monotherapy; prostate cancer; radiotherapy